Sort
39,280 grants matching “leukemia”
Gradient Biomaterials to Investigate Niche Regulation of Hematopoiesis
$335,859Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2014 · DK
The Development of Stat3 Inhibitors
$335,842John S McMurray · University Of Tx Md Anderson Can Ctr · R01 · FY2007 · CA
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies
$335,822Kristy L Richards · Cornell University · R01 · FY2015 · CA
The Development of Stat3 Inhibitors
$335,797John S McMurray · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Oncogene-Induced Evasion from Apoptosis
$335,750Beth Israel Deaconess Medical Center · R01 · FY2005 · CA
Control of retrovirus CNS disease by redox modulation
$335,736University Of Texas Md Anderson Can Ctr · R01 · FY2002 · NS
An Integrative Bioinformatics Platform with Application in Single Cancer Cells
$335,681Lana X Garmire · University Of Michigan At Ann Arbor · R01 · FY2018 · LM
ADHESION MOLECULES MEDIATING SKIN TROPISM IN ACUTE GVHD
$335,679Brigham And Women'S Hospital · R01 · FY2000 · CA
Identifying and targeting evolutionary trajectories in cancer
$335,673Michael Hemann · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Epigenetic modulation of cellular aging to improve CAR-T therapy for solid tumors
$335,648Benedetta Nicolis Di Robilant · Dorian Therapeutics, Inc. · R43 · FY2021 · CA
Endogenous CNTF receptors and adult, in vivo neurogenesis
$335,639Alexander John Maclennan · University Of Cincinnati · R01 · FY2011 · NS
Regulation of V(D)J recombination by Rag2 C terminus
$335,610Patricia Cortes · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · AI
Regulation of V(D)J recombination by Rag2 C terminus
$335,610Patricia Cortes · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · AI
Regulation of V(D)J recombination by Rag2 C terminus
$335,610Patricia Cortes · Icahn School Of Medicine At Mount Sinai · R01 · FY2014 · AI
Gradient Biomaterials to Investigate Niche Regulation of Hematopoiesis
$335,585Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2015 · DK
Therapy-Related Leukemia Following Autologous Transplantation for Lymphoma
$335,563Ravi Bhatia · Beckman Research Institute/City Of Hope · P50 · FY2008 · CA
Molecular Determinants of Decitabine Response
$335,554Timothy J Ley · Washington University · P50 · FY2015 · CA
DEVELOPMENTAL POTENTIAL - NOVEL FETAL LYMPHOID PRECURSOR
$335,512Mount Sinai School Of Medicine Of Nyu · R01 · FY2002 · HL
Defining and targeting a novel pathway for central nervous system leptomeningeal metastasis
$335,505Dorothy A Sipkins · Duke University · R01 · FY2024 · CA
Factor-general characterization of dynamic transcriptional stress responses
$335,504Adam Charles Siepel · Cornell University · R01 · FY2014 · HG
Endogenous CNTF receptors and adult, in vivo neurogenesis
$335,502Alexander John Maclennan · University Of Cincinnati · R01 · FY2012 · NS
GTI-2040: An anti-sense strategy to reduce ribonucleotide reductase in AML
$335,500Guido Marcucci · Ohio State University · R21 · FY2009 · CA
GTI-2040: An anti-sense strategy to reduce ribonucleotide reductase in AML
$335,500Guido Marcucci · Ohio State University · R21 · FY2010 · CA
Imaging and Radiation Oncology Core (IROC) Group
$335,460David S Followill · American College Of Radiology · U24 · FY2018 · CA
Project 1: HDAC inhibition and GVHD
$335,457Pavan Reddy · Icahn School Of Medicine At Mount Sinai · P01 · FY2018 · CA